New hope for liver cancer patients who have run out of options
NCT ID NCT05117957
Summary
This study tested whether the drug sorafenib could help control advanced liver cancer in patients whose disease had worsened after at least one prior treatment. Fifty participants took a daily pill and were monitored to see if the cancer stopped growing and how long they lived. The main goals were to measure how long the treatment kept the cancer from getting worse and to check for side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Cancer Center, Korea
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.